Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-06-10

Clinical Trial Update: Lanreotide Levels in Acromegaly

View source ↗

Summary

This clinical trial update covers lanreotide levels in acromegaly; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lanreotide (lanreotide)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Acromegaly | Status: UNKNOWN